Genetic risk stratification in autosomal dominant polycystic kidney disease relies primarily on identification of pathogenic variants in PKD1 and PKD2, which account for the vast majority of cases. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.